AZD2171 (Cediranib) is active in first line metastatic renal cell carcinoma (RCC): Interim results of a phase II trial. A trial of the PMH Phase II Consortium

被引：0
|
作者：
Sridhar, Srikala S. [1 ]
Mackenzie, Mary J. [2 ]
Hotte, Sebastien J. [3 ]
Mukherjee, Som D. [3 ]
Murray, Nevin [4 ]
Tannock, Ian F. [1 ]
Haider, Masoom A. [1 ]
Chen, Eric X. [1 ]
Wang, Lisa [1 ]
Srinivasan, Ranuka [1 ]
Ivy, S. Percy [5 ]
Moore, Malcolm J. [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON, Canada
[2] London Reg Canc Ctr, Toronto, ON, Canada
[3] Juravinski Canc Ctr, Hamilton, ON, Canada
[4] BC Canc Agncy, Vancouver, BC, Canada
[5] Natl Canc Inst, CTEP, Bethesda, MD USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3337S / 3338S
页数：2
相关论文
共 50 条
  • [21] Phase II trial of aflibercept (VEGF Trap) in previously treated patients with metastatic colorectal cancer (MCRC): A PMH phase II consortium trial
    Tang, P.
    Cohen, S. J.
    Bjarnason, G. A.
    Kollmannsberger, C.
    Virik, K.
    MacKenzie, M. J.
    Brown, J.
    Wang, L.
    Chen, A. P.
    Moore, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] Phase II trial of cediranib (AZD 2171) in docetaxel-resistant, castrate-resistant prostate cancer (CRPC)
    Karakunnel, J. J.
    Gulley, J. L.
    Arlen, P.
    Mulquin, M.
    Wright, J.
    Turkbey, I. B.
    Choyke, P.
    Ahlers, C. M.
    Figg, W. D.
    Dahut, W.
    ANNALS OF ONCOLOGY, 2008, 19 : 25 - 25
  • [23] Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma
    Vaishampayan, Ulka N.
    Heilbrun, Lance K.
    Shields, Anthony F.
    Lawhorn-Crews, Jawana
    Baranowski, Karen
    Smith, Daryn
    Flaherty, Lawrence E.
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (01) : 69 - 75
  • [24] Phase II trial of suramin in patients with metastatic renal cell carcinoma
    Dreicer, R
    Smith, DC
    Williams, RD
    See, WA
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (02) : 183 - 186
  • [25] A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma
    Lee, J
    Hodgson, D
    Chow, E
    Bezjak, A
    Catton, P
    Tsuji, D
    O'Brien, M
    Danjoux, C
    Hayter, C
    Warde, P
    Gospodarowicz, MK
    CANCER, 2005, 104 (09) : 1894 - 1900
  • [26] Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma
    Patel, Premal H.
    Kondagunta, G. Varuni
    Schwartz, Lawrence
    Ishill, Nicole
    Bacik, Jennifer
    DeLuca, John
    Russo, Paul
    Motzer, Robert J.
    INVESTIGATIONAL NEW DRUGS, 2008, 26 (03) : 273 - 276
  • [27] Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma
    Premal H. Patel
    G. Varuni Kondagunta
    Lawrence Schwartz
    Nicole Ishill
    Jennifer Bacik
    John DeLuca
    Paul Russo
    Robert J. Motzer
    Investigational New Drugs, 2008, 26 : 273 - 276
  • [28] Phase II Trial of Suramin in Patients with Metastatic Renal Cell Carcinoma
    Robert Dreicer
    David C. Smith
    Richard D. Williams
    William A. See
    Investigational New Drugs, 1999, 17 : 183 - 186
  • [29] A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma
    Lee, J
    Hodgson, D
    Chow, E
    Beziak, A
    Tsuji, D
    Catton, P
    Danjoux, C
    Hayter, C
    Gospodarowicz, M
    Warde, P
    RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S3 - S3
  • [30] Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma
    Ulka N. Vaishampayan
    Lance K. Heilbrun
    Anthony F. Shields
    Jawana Lawhorn-Crews
    Karen Baranowski
    Daryn Smith
    Lawrence E. Flaherty
    Investigational New Drugs, 2007, 25 : 69 - 75
12345